Relative Contribution of Clinical and Molecular Features to Outcome Within Low and High Risk T and N Groups in Patients with Stage III Colon Cancers (Alliance)
- Citation:
- JCO vol 37 (no. 15_suppl) 3520
- Meeting Instance:
- ASCO 2019
- Year:
- 2019
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3169
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- GI
- Pharmas:
- BMS, Pfizer, Pharmacia &Upjohn, Sanofi-Synthelabo
- Grants:
- U10CA180821, U10CA180882;
- Corr. Author:
- Authors:
- Frank A. Sinicrope Luke Huebner Pierre Laurent-Puig Thomas C. Smyrk Josep Tabernero Enrico Mini Richard M. Goldberg Gunnar Folprecht Jean Luc Van Laethem Karine Le Malicot Qian Shi Steven R. Alberts Julien Taieb
- Networks:
- LAPS-MN026, LAPS-OH007
- Study
- NCCTG-N0147
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: